Cargando…
Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study
BACKGROUND: Different strategies have been designed for clinical implementation of cell-free DNA (cfDNA) testing. We aimed to evaluate the performance of a contingent strategy based on conventional screening and offering cfDNA to the intermediate-risk group, for the screening for trisomies 21, 18 an...
Autores principales: | Sánchez-Durán, María Ángeles, Bernabeu García, Andrea, Calero, Inés, Ramis Fossas, Jordi, Illescas, Tamara, Avilés, María Teresa, Maiz, Nerea, Carreras, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676567/ https://www.ncbi.nlm.nih.gov/pubmed/31370808 http://dx.doi.org/10.1186/s12884-019-2434-0 |
Ejemplares similares
-
Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital
por: Sánchez-Durán, María Ángeles, et al.
Publicado: (2019) -
A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023) -
Reference values for interleukin‐6 in the amniotic fluid of asymptomatic pregnant women
por: del Barco, Ester, et al.
Publicado: (2023) -
The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis
por: Prefumo, Federico, et al.
Publicado: (2019) -
Cell‐free DNA screening for rare autosomal trisomies and segmental chromosome imbalances
por: Raymond, Yvette C., et al.
Publicado: (2022)